- Filed
- Oct 31, 2014 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2014 · Oct 29, 2014 | 16.06M sh |
| Shares Diluted | Q3 2014 · Sep 30, 2014 | 16.17M sh |
| Shares Diluted | Q3 2014 · Sep 30, 2014 | 16.15M sh |
| Shares Diluted | Q3 2014 · Sep 30, 2013 | 16.07M sh |
| Shares Diluted | Q3 2014 · Sep 30, 2013 | 16.24M sh |
| Stock Repurchased | Q3 2014 · Sep 30, 2014 | $0 |
| Stock Repurchased | Q3 2014 · Sep 30, 2013 | $9.96M |
| Capex | Q3 2014 · Sep 30, 2014 | $2.52M |
| Capex restated | Q3 2014 · Sep 30, 2013 | $2.72M |
| Operating Cash Flow | Q3 2014 · Sep 30, 2014 | −$36.45M |
| Operating Cash Flow restated | Q3 2014 · Sep 30, 2013 | $6.43M |
| Long Term Debt | Q3 2014 · Sep 30, 2014 | $4.79M |
| Long Term Debt | Q3 2014 · Dec 31, 2013 | $55.33M |
| Short Term Debt | Q3 2014 · Sep 30, 2014 | $50.91M |
| Short Term Debt | Q3 2014 · Dec 31, 2013 | $952K |
| Short Term Investments | Q3 2014 · Sep 30, 2014 | $23.92M |
| Short Term Investments | Q3 2014 · Dec 31, 2013 | $7.99M |
| Cash And Equivalents | Q3 2014 · Sep 30, 2014 | $50.74M |
| Cash And Equivalents | Q3 2014 · Dec 31, 2013 | $106.93M |
| Cash And Equivalents restated | Q3 2014 · Sep 30, 2013 | $70.51M |
| Cash And Equivalents restated | Q3 2014 · Dec 31, 2012 | $105.94M |
| Stockholders Equity | Q3 2014 · Sep 30, 2014 | $147.8M |
| Stockholders Equity | Q3 2014 · Dec 31, 2013 | $45.62M |
| Current Liabilities | Q3 2014 · Sep 30, 2014 | $117.69M |
| Current Liabilities | Q3 2014 · Dec 31, 2013 | $104.1M |
| Current Assets | Q3 2014 · Sep 30, 2014 | $176.62M |
| Current Assets | Q3 2014 · Dec 31, 2013 | $240.13M |
| Total Assets | Q3 2014 · Sep 30, 2014 | $282.69M |
| Total Assets | Q3 2014 · Dec 31, 2013 | $366.84M |
| Eps Diluted | Q3 2014 · Sep 30, 2014 | $6.57 |
| Eps Diluted | Q3 2014 · Sep 30, 2014 | $6.13 |
| Eps Diluted restated | Q3 2014 · Sep 30, 2013 | −$0.53 |
| Eps Diluted restated | Q3 2014 · Sep 30, 2013 | −$0.45 |
| Eps Basic | Q3 2014 · Sep 30, 2014 | $6.58 |
| Eps Basic | Q3 2014 · Sep 30, 2014 | $6.15 |
| Eps Basic restated | Q3 2014 · Sep 30, 2013 | −$0.53 |
| Eps Basic restated | Q3 2014 · Sep 30, 2013 | −$0.45 |
| Sga Expense | Q3 2014 · Sep 30, 2014 | $18.23M |
| Sga Expense | Q3 2014 · Sep 30, 2014 | $56.56M |
| Sga Expense restated | Q3 2014 · Sep 30, 2013 | $18.35M |
| Sga Expense restated | Q3 2014 · Sep 30, 2013 | $59.4M |
| Net Income | Q3 2014 · Sep 30, 2014 | $106.17M |
| Net Income | Q3 2014 · Sep 30, 2014 | $98.97M |
| Net Income | Q3 2014 · Sep 30, 2013 | −$8.47M |
| Net Income | Q3 2014 · Sep 30, 2013 | −$7.23M |
| Operating Income | Q3 2014 · Sep 30, 2014 | −$11.42M |
| Operating Income | Q3 2014 · Sep 30, 2014 | −$13.69M |
| Operating Income restated | Q3 2014 · Sep 30, 2013 | −$11.55M |
| Operating Income restated | Q3 2014 · Sep 30, 2013 | −$16.02M |
| Gross Profit | Q3 2014 · Sep 30, 2014 | $53.5M |
| Gross Profit | Q3 2014 · Sep 30, 2014 | $191.8M |
| Gross Profit restated | Q3 2014 · Sep 30, 2013 | $56.28M |
| Gross Profit restated | Q3 2014 · Sep 30, 2013 | $202.64M |
| Cost Of Revenue | Q3 2014 · Sep 30, 2014 | $37.26M |
| Cost Of Revenue | Q3 2014 · Sep 30, 2014 | $121.42M |
| Cost Of Revenue restated | Q3 2014 · Sep 30, 2013 | $40.75M |
| Cost Of Revenue restated | Q3 2014 · Sep 30, 2013 | $133.39M |
| Revenue | Q3 2014 · Sep 30, 2014 | $90.75M |
| Revenue | Q3 2014 · Sep 30, 2014 | $313.22M |
| Revenue restated | Q3 2014 · Sep 30, 2013 | $97.03M |
| Revenue restated | Q3 2014 · Sep 30, 2013 | $336.02M |